Atlas Trials

Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer.

Clinical trial NCT04453423 · UNKNOWN

Trial details

NCT number
NCT04453423
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-squamous Non-small-cell Lung Cancer
Start date
2020-07-01
Primary completion
2022-07-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.